Richard David Abbott - May 23, 2025 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Role: President
Signature: Richard David Abbott
Stock symbol: CODX
Transactions as of: May 23, 2025
Transactions value $: -$1,723
Form type: 4
Date filed: 5/27/2025, 04:09 PM
Previous filing: Nov 25, 2024
Next filing: Aug 15, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Abbott Richard David	President	C/O CO-DIAGNOSTICS, INC., 2401 S. FOOTHILL DRIVE, SUITE D, SALT LAKE CITY	Richard David Abbott	2025-05-27	0002016256

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CODX	Common Stock	Award	$0	+20K	+143.73%	$0.00	33.9K	May 23, 2025	Direct	F1
transaction	CODX	Common Stock	Disposed to Issuer	-$1.72K	-7.18K	-21.17%	$0.24	26.7K	May 23, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CODX	Restricted Stock Unit	Options Exercise	$0	-20K	-13.29%	$0.00	130K	May 23, 2025	Common Stock	150K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Included in 120,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024.
F2	Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Content

Included in 120,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024.

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.